{"id":"NCT00344175","sponsor":"Kowa Research Europe","briefTitle":"Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors","officialTitle":"Double-blind follow-on Study of Pitavastatin (4mg) Versus Simvastatin (40mg and 80mg) With a Single-blind Extension of Treatment in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia and 2 or More Risk Factors for Coronary Heart Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-06","primaryCompletion":"2007-08","completion":"2007-08","firstPosted":"2006-06-26","resultsPosted":"2010-01-18","lastUpdate":"2010-02-02"},"enrollment":178,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia","Dyslipidemia","Coronary Heart Disease"],"interventions":[{"type":"DRUG","name":"pitavastatin","otherNames":[]},{"type":"DRUG","name":"simvastatin","otherNames":[]}],"arms":[{"label":"Pitavastatin 4 mg","type":"EXPERIMENTAL"},{"label":"Simvastatin 40mg/80mg","type":"ACTIVE_COMPARATOR"}],"summary":"This is a sixteen-week follow-on and 28 week single-blind extension study for patients who participated in study NK-104-304.","primaryOutcome":{"measure":"Number of Patients Attaining NCEP LDL-C Target at Week 16","timeFrame":"16 weeks","effectByArm":[{"arm":"Pitavastatin 4 mg","deltaMin":98,"sd":null},{"arm":"Simvastatin 40mg/80mg","deltaMin":45,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":1},"locations":{"siteCount":28,"countries":["Denmark","Netherlands","Spain","Sweden"]},"refs":{"pmids":["21874537"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":121},"commonTop":["Nasopharyngitis","Back pain","Myalgia","Influenza","Arthralgia"]}}